CD80 and CD86 on dendritic cells 16, 17 but it is unclear whether the in vivo stimulatory activity of antigen-presenting cells is affected by CTLA-4. Thus, the cellular site of action of CTLA-4 in controlling tolerance requires further examination.
In addition, the antigen specificity of expanding CD4 + T cell populations in Ctla4 −/− mice has not been examined. Specifically, it is unclear whether these proliferating T cells are reactive generally to self major histocompatibility complex, to ubiquitous antigens and/or to many tissue-specific antigens. Some relationship between the pathology of Ctla4 −/− mice and T cell antigen receptor (TCR) specificity is suggested by the observation that the introduction of rearranged αβTCR transgenes onto the Ctla4 −/− genetic background eliminates the fatal lymphoproliferation 18, 19 . However, no direct evidence has supported the interpretation that Ctla4 −/− mice develop an antigenspecific autoimmune disease. For example, spectratype analysis of the TCRβ complementarity-determining region 3 regions from T cell populations expanding in Ctla4 −/− mice has shown a diverse and unbiased repertoire and has been interpreted as being reflective of antigen-independent T cell activation 20 . Furthermore, no reports so far have directly analyzed the antigen specificity of CD4 + T cell clones obtained from Ctla4 −/− mice. However, resolving the nature of the TCR repertoire of T cell populations expanding in Ctla4 −/− mice is important for two reasons. First, mutations in CTLA4 are associated with several autoimmune diseases, including hypothyroidism and type 1 diabetes 21 . Second, treatment with antibody to CTLA-4 (anti-CTLA-4) is a potential immunotherapeutic approach in the treatment of cancer 22 , so it is important to determine the potential for activating self antigen-specific T cells. The inhibitory immunoregulatory receptor CTLA-4 is critical in maintaining self-tolerance, but the mechanisms of its actions have remained controversial. Here we examined the antigen specificity of tissue-infiltrating CD4 + T cells in Ctla4 −/− mice. After adoptive transfer, T cells isolated from tissues of Ctla4 −/− mice showed T cell antigen receptor (TCR)-dependent accumulation in the tissues from which they were derived, which suggested reactivity to tissue-specific antigens. We identified the pancreasspecific enzyme PDIA2 as an autoantigen in Ctla4 −/− mice. CTLA-4 expressed either on PDIA2-specific effector cells or on regulatory T cells was sufficient to control tissue destruction mediated by PDIA2-specific T cells. Our results demonstrate that both cell-intrinsic and non-cell-autonomous actions of CTLA-4 operate to maintain T cell tolerance to a self antigen. 
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A r t i c l e s
To address those issues, we used an approach similar to that used in analyzing the TCR repertoire of T reg cells 23, 24 . By crossing the DO11.10 TCRβ transgene 25 onto the Ctla4 −/− genetic background to restrict TCRβ specificity, we found that the lethal multiorgan lymphoproliferative disorder and expansion of CD4 + T cell populations in Ctla4 −/− mice was maintained, but the mice showed a slightly lower rate of death. By analyzing the antigen specificity of the proliferating CD4 + T cells in Ctla4 −/− mice, we found that Ctla4 −/− T cells infiltrating peripheral nonlymphoid tissues were composed of separate populations of different tissue-specific T cells. We identified one autoantigen recognized by these tissue-infiltrating Ctla4 −/− T cells, isolated a specific TCRαβ reactive to this antigen and examined the in vivo activity of T cells with this TCR specificity. Our results show that CTLA-4 expressed on the antigen-specific effector T cells greatly diminished their pathogenicity in vivo but that CTLA-4 expression by T reg cells was sufficient to control the accumulation of self-reactive, tissue-specific effector T cells in target tissues. Together our findings show both cell-intrinsic and non-cell-autonomous actions of CTLA-4.
RESULTS
Disease in
Ctla4 −/− mice with a fixed TCR repertoire We compared Ctla4 −/− mice with Ctla4 −/− mice expressing the DO11.10 TCRβ chain (DOβCtla4 −/− mice; Fig. 1a) . Ctla4 −/− mice uniformly died by 4 weeks of age, whereas DOβCtla4 −/− mice had a slower rate of death, with 75% of mice dying by 7 weeks of age, and 10% of mice still surviving by 10 weeks (Fig. 1a) . Thus, fixing the TCRβ chain prolonged but did not eliminate the disease in Ctla4 −/− mice. This slower disease course allowed us to better examine the characteristics and tissue specificity of CD4 + T cells. CD4 + T cells in DOβCtla4 −/− mice had an activated surface phenotype (Fig. 1b) , in agreement with published reports of activation of CD4 + T cells in Ctla4 −/− mice [2] [3] [4] . Specifically, although DOβCtla4 +/− and DOβCtla4 +/+ mice had a normal distribution of naive and memory T cells, with 60% of CD4 + splenic T cells having a naive surface phenotype, DOβCtla4 −/− mice had a much lower percentage of naive T cells, with 70% of T cells having an activated-memory phenotype (Fig. 1b) . Finally, fixation of the TCRβ chain in Ctla4 −/− mice did not alter the multiorgan nature of disease in Ctla4 −/− mice, as DOβCtla4 −/− mice had lymphocytic infiltration in the heart, lungs and pancreas, whereas DOβCtla4 +/− mice had normal tissue histology (Fig. 1c) .
Tissue-specific accumulation of Ctla4 −/− T cells So far, tissue-infiltrating T cells from Ctla4 −/− mice have not been cloned, nor has their antigen specificity been characterized 26, 27 . We used DOβCtla4 −/− mice as donors of T cells isolated from various tissues and first set out to examine their pattern of migration and population expansion in recipient mice deficient in recombinationactivating gene 2 (Rag2 −/− mice in vivo and migrated into many organs, including the pancreas, lungs and heart (Fig. 2a) . In contrast, T cells isolated from peripheral organs of DOβCtla4 −/− mice accumulated selectively in their organ of origin (Fig. 2a) . For example, CD4 + T cells originally isolated from the lungs of DOβCtla4 −/− mice showed a greater accumulation in the lungs than in the pancreas or heart of recipient Rag2 −/− mice. Notably, CD4 + T cells isolated from the pancreas of DOβCtla4 −/− mice accumulated selectively in the pancreas of recipient Rag2 −/− mice and not the lungs or heart of recipient Rag2 −/− mice. Furthermore, the selective migration of CD4 + T cells isolated from DOβCtla4 −/− mice was associated histologically with the induction of tissue pathology (Fig. 2b) . Specifically, CD4 + T cells isolated from the spleen of DOβCtla4 −/− mice caused an intense tissue-destructive infiltration in the pancreas, heart and lungs of Rag2 −/− recipients. CD4 + T cells isolated from the lungs of DOβCtla4 −/− mice elicited a strong peribronchial infiltration with perivascular infiltration and associated epithelial changes in the lungs of Rag2 −/− recipients ( Fig. 2b) but caused no changes in the pancreas or heart. Finally, CD4 + T cells isolated from the pancreas of DOβCtla4 −/− mice caused tissuedestructive lesions of the exocrine pancreas in Rag2 −/− recipients but selectively spared the pancreatic islets, lungs and heart. Tissue lesions caused by the transfer of DOβCtla4 −/− T cells were histologically similar to those caused by Ctla4 −/− T cells (Supplementary Fig. 1 ), which suggested that the tissue-specific accumulation of DOβCtla4 −/− T cells was not an artifact introduced by transgenic DO11.10 TCRβ chain.
TCR specificity determines tissue-specific accumulation
The tissue-specific accumulation of DOβCtla4 −/− T cells could have been due to either reactivity to tissue-specific antigens or to selective homing properties 'imprinted' after tissue entry, for example, by selective expression of chemokine receptors. To distinguish between those possibilities, we made a TCRα retroviral library from tissueinfiltrating CD4 + T cells of DOβCtla4 −/− mice and tested the migration of T cells expressing TCRs isolated from tissues. We cloned TCRα cDNA made from pancreas-infiltrating T cells of DOβCtla4 −/− mice into a retroviral vector expressing Thy-1.1 as a marker to produce a TCRα library (Supplementary Fig. 2 ). We infected naive Rag2 −/− DO11.10 T cells expressing or lacking CTLA-4 with the complete TCRα library or with empty retrovirus (Supplementary Fig. 3 ) and adoptively transferred the cells into Rag2 −/− mice. Thy-1.1 + T cells expressing the TCRα library, but not those expressing the empty retrovirus, showed selective accumulation in pancreatic lymph nodes and pancreas but not in inguinal lymph nodes or lungs of recipient mice (Fig. 3a) . As pancreas-selective infiltration could reflect either selective entry or selective proliferation in situ, we analyzed the kinetics and proliferation of tissue-infiltrating T cells ( Supplementary Fig. 4 ). T cells expressing the pancreas-derived TCRα library showed similar early entry into the lungs and pancreas at day 7 after adoptive transfer, although T cells were proliferating more in the pancreas even at this time ( Supplementary Fig. 4a-c) . At later times, this greater accumulation and proliferation in the pancreas than in the lungs persisted and was statistically significant. Analysis by adoptive transfer of cells isolated directly from nonlymphoid tissues of Ctla4 −/− mice was precluded by the fact that such a large percentage of these cells proliferated immediately after isolation and before adoptive transfer ( Supplementary Fig. 4d,e) . The percentage of TCRα library-expressing T cells that accumulated in pancreatic lymph nodes and pancreas was unaffected by the presence or absence of CTLA-4 (Fig. 3b, left and middle). However, we detected significantly more library-derived Ctla4 −/− cells than library-derived Ctla4 +/+ T cells in the pancreatic tissue (Fig. 3b, right) . Also, library-derived Ctla4 +/+ T cells caused minimal pancreatic disease, whereas library-derived Ctla4 −/− T cells caused exocrine-specific tissue destruction (Fig. 3c) . In summary, TCRα chains derived from pancreas-infiltrating T cells of Ctla4 −/− mice are sufficient to confer selective accumulation of Ctla4 −/− T cells in the pancreas as a result of tissue-specific Ctla4 −/− T cell proliferation. Furthermore, these antigen-specific T cells cause tissue injury in the absence of CTLA-4.
PDIA2 is an autoantigen recognized by Ctla4 −/− T cells Ctla4 −/− mice and DOβCtla4 −/− mice showed intense lymphocytic infiltration of the exocrine pancreas that largely spared the pancreatic islets ( Fig. 1c and data not shown) . When monitored for development of autoimmune diabetes, DOβCtla4 −/− mice had significantly lower blood glucose concentrations than did DOβCtla4 +/-mice (P < 0.05; Supplementary Fig. 5a ). In addition, when we transferred Fig. 5b ). These results suggested that Ctla4 −/− T cells may react to a pancreasspecific self antigen selectively expressed in acinar tissue. Published studies have suggested a candidate for such a self antigen 28 . Nonobese diabetic mice develop immune-mediated destruction of beta cells of pancreatic islets, but nonobese diabetic mice deficient in the autoimmune regulator Aire show immune cell reactivity to pancreatic acinar cells and make autoantibodies specific for PDIA2 (protein disulfide isomerase-associated 2), an acinar-specific enzyme 28 . As DOβCtla4 −/− mice showed acinar tissue-restricted autoimmunity, we sought to determine if PDIA2 is an autoantigen in Ctla4 −/− mice. We isolated T cells from the pancreatic lymph nodes of Ctla4 +/+ or Ctla4 −/− mice and activated the cells in vitro in the presence or absence of PDIA2 protein. T cells from Ctla4 −/− mice, but not those from Ctla4 +/+ mice, produced a substantial amount of IL-2 in response to PDIA2 (Fig. 4a) . Furthermore, Ctla4 −/− mice had antibodies reactive to PDIA2 in the serum, but Ctla4 +/+ mice did not (Fig. 4b) . Therefore, PDIA2 seems to be an authentic autoantigen in Ctla4 −/− mice. We tested the reactivity of Ctla4 −/− T cells to other proteins, such as carbonic anhydrase II, α-amylase, lactoferrin and carboxypeptidase B, which have been suggested to be associated with autoimmune pancreatitis 29, 30 . However, none of these proteins elicited detectable secretion of IL-2 from Ctla4 −/− T cells (Supplementary Fig. 6 ).
PDIA2-specific TCRs from pancreas-infiltrating Ctla4 −/− T cells
To examine how CTLA-4 regulates autoreactive T cells in vivo, we sought to isolate an authentic autoantigen-specific TCR from Ctla4 −/− T cells. We modified a T cell hybridoma (58α − β − ) to express the DO11.10 TCRβ chain along with a green fluorescent protein (GFP) reporter inducible by the transcription factor NFAT. We isolated pancreasinfiltrating CD4 + T cells from DOβCtla4 −/− mice and generated full-length TCRα cDNA, cloned it into a modified retroviral vector and expressed it in this hybridoma (Supplementary Fig. 7) . We then examined CD3 + hybridoma cells for TCR reactivity to various antigens by assaying for the induction of GFP. As a control, when the DO11.10 TCRα (DOα) was expressed, hybridoma cells reacted robustly to both to anti-CD3 stimulation and to ovalbumin (OVA) peptide; hybridomas expressing the TCRα library responded to anti-CD3 but not OVA (Fig. 5a) .
First we assessed whether hybridomas expressing the TCRα library had TCRs that reacted to defined antigens from the endocrine pancreas. We found no responses to pancreatic beta cells, insulin, insulin peptide 9-23 or purified glucagon (Fig. 5b) , consistent with the lack of diabetes in DOβCtla4 −/− mice. Hyridomas also did not respond to the exocrine proteins carbonic anhydrase II, α-amylase, lactoferrin or carboxypeptidase B (Supplementary Fig. 6 ). However, approximately 2% of the hybridomas expressing the TCRα library reacted to PDIA2 (Fig. 5b) . We isolated these hybridoma populations by sorting GFP + cells after stimulation with PDIA2 and noted enriched PDIA2 reactivity in sorted populations (Fig. 5c) . In contrast, we observed no enrichment of insulin reactivity in sorted GFP + limited dynamic range of the hybridoma assay could have introduced a bias in the representation of antigen-reactive T cells identified in this screen. Nevertheless, PDIA-2 was the only autoantigen identified so far by this approach. When we cloned these enriched PDIA2-reactive hybridomas cells by limiting dilution, they continued to show PDIA2 reactivity in vitro (Fig. 5d) .
We used one such hybridoma, clone 29, as a source of a PDIA2-reactive TCRα chain (29TCRα; Supplementary Fig. 8) . Expression of the 29TCRα chain in the DOβ + hybridomas regenerated PDIA2-specific reactivity (Fig. 5e) , which confirmed that this combination of TCRβ and TCRα chains generates a TCR specific for an autoantigen in Ctla4 −/− mice. Expression of the 29TCRα chain in naive T cells also conferred PDIA2-specific reactivity ( Supplementary  Fig. 9 ). We transduced empty Thy-1.1 + retrovirus or 29TCRα-expressing Thy-1.1 + retrovirus into Ctla4 +/+ or Ctla4 −/− Rag2 −/− DO11.10 transgenic T cells. Expression of the 29TCRα chain endowed T cells with the ability to undergo proliferation in response to PDIA2, but expression of the empty vector did not. In contrast, empty vector and 29TCRα retrovirus left the original TCR reactivity to OVA peptide intact.
PDIA2-specific Ctla4 −/− T cells infiltrate the pancreas
Expression of the 29TCRα chain in naive DO11.10 Rag2 −/− T cells conferred pancreatic accumulation. Specifically, when the 29TCRα chain was expressed in DO11.10 Rag2 −/− T cells adoptively transferred into Rag2 −/− recipients, we detected substantially greater accumulation of Thy-1.1 + cells in the pancreatic lymph nodes and pancreas but not in the inguinal lymph nodes, lungs, spleen or axillary lymph nodes (Fig. 6a  and data not shown) . Notably, Ctla4 +/+ and Ctla4 −/− 29TCRα T cells accumulated in equal numbers in pancreatic lymph nodes (Fig. 6b) , but infiltration of the pancreas itself was greatly affected by the presence of CTLA-4. Approximately tenfold more T cells infiltrated the pancreas when the 29TCRα chain was expressed in Ctla4 −/− T cells than when it was expressed in Ctla4 +/+ T cells (Fig. 6b) . Again, the pancreatic infiltration was exocrine specific and was not present in the heart or lungs (Fig. 6c) . Notably, Ctla4 +/+ T cells expressing 29TCRα did not express the transcription factor Foxp3 in Rag2 −/− recipients (data not shown). In addition, 29TCRα + T cells did not develop into CD4 + CD25 + cells in bone marrow chimeras regardless of CTLA-4 expression (Supplementary Fig. 10a ). In these bone marrow chimeras, Ctla4 +/+ 29TCRα + T cells caused minimal pancreatitis, whereas Ctla4 −/− 29TCRα + T cells induced severe pancreatic tissue destruction (Supplementary Fig. 10b ). Together these results suggest that CTLA-4 on autoantigen-specific effector T cells diminishes pathogenicity by inhibiting their infiltration into target tissues. (Fig. 7a) . However, cotransfer of Ctla4 +/+ T reg cells resulted in the infiltration of significantly fewer PDIA2-specific T cells into the pancreas (Fig. 7a) and prevented the destruction of pancreatic tissue by Ctla4 −/− PDIA2-specific T cells (Fig. 7b) . In contrast, cotransferred Ctla4 −/− T reg cells failed to inhibit the infiltration of PDIA2-specific T cells into the pancreas and destruction of pancreatic tissue (Fig. 7b) . We confirmed that result in mixed-bone marrow chimeras in which CTLA-4-expressing cells derived from wild-type BALB/c mice controlled pancreatic tissue destruction by Ctla4 −/− PDIA2-specific T cells (Supplementary Fig. 10 ). These results demonstrate that autoimmune responses by tissue-specific Ctla4 −/− T cells can be regulated by CTLA-4-expressing T reg cells.
DISCUSSION
At least two questions regarding CTLA-4 have remained unanswered. What is the specificity of CD4 + T cells that proliferate and infiltrate the nonlymphoid organs in Ctla4 −/− mice? And on what cells does CTLA-4 exert its inhibitory effects? Specifically, it has been unclear whether CD4 + T cells in Ctla4 −/− mice are reactive to self major histocompatibility complex proteins, to ubiquitous antigens presented by major histocompatibility complex or to particular tissue-specific antigens. Although some evidence has suggested a cellautonomous action for the CTLA-4 cytoplasmic domain 32, 33 , other work has supported the idea of a non-cell-autonomous effect of CTLA-4 on cells expressing CTLA-4 ligands 34, 35 . Resolving these distinctions is important, as CTLA-4 polymorphisms have been associated with autoimmune diseases 36 and CTLA-4 blockade is an emerging cancer immunotherapy 22 . Some evidence has suggested that proliferating Ctla4 −/− T cells are not antigen specific 20 . TCR spectratyping of peripheral T cells from Ctla4 −/− mice and mice deficient in the kinase Jak3 has indicated that Jak3-deficient T cells have a restricted and highly biased TCR repertoire but Ctla4 −/− T cells have a diverse and unbiased TCR repertoire 20 . This was interpreted to suggest that Ctla4 −/− T cells are activated by TCR-major histocompatibility complex interactions involved in the survival and/or homeostasis of peripheral T cells 37, 38 but not necessarily by tissue-specific antigens. However, another study has identified restricted TCR spectratypes in splenic Ctla4 −/− T cells 39 , which suggests that particular combinations of variable and joining segments analyzed previously were not entirely representative of the Ctla4 −/− TCR repertoire. Neither study examined Ctla4 −/− T cells from tissues other than the spleen 20, 39 . Therefore, both studies may have missed effects on TCR repertoire bias seen in tissue-infiltrating T cells.
Introducing the DOβ chain onto the Ctla4 −/− background did not eliminate the lethal multiorgan infiltration of CD4 + T cells, but it did slow disease enough to allow us to examine the specificity of tissue-infiltrating T cells. Unexpectedly, we found that T cells from particular tissues, such as the pancreas, showed selective accumulation in their tissue of origin after adoptive transfer into Rag2 −/− hosts. Selective accumulation alone does not indicate reactivity to tissue-specific antigens, as these T cells could have acquired expression of chemokine receptors (or other receptors) that mediate such activity. However, a TCRα retroviral library made from pancreasinfiltrating Ctla4 −/− T cells, when expressed in naive DOβ T cells, also conferred pancreas-specific accumulation, which suggested that the accumulation of Ctla4 −/− T cells was TCR dependent and antigen specific. These observations are the first to our knowledge to show that tissue-infiltrating CD4 + T cells in Ctla4 −/− mice are reactive to tissue-specific antigens.
We identified PDIA2 as an autoantigen of Ctla4 −/− mice. PDIA2 was originally discovered as an autoantigen recognized by serum from Aire −/− nonobese diabetic mice 28 , which develop exocrine pancreas-specific inflammation that spares islets and does not induce diabetes, similar to our findings in DOβCtla4 −/− mice. How Aire might regulate the emergence of PDIA2-reactive clones is unclear, as PDIA2 expression in thymic epithelial cells is not lower in Aire −/− nonobese diabetic mice 28 . Aire might act to eliminate PDIA2-reactive clones in the thymus by influencing the processing and/or presentation of PDIA2, rather than by influencing Pdia2 transcription 40 . As thymic selection is normal in Ctla4 −/− mice 4 , CTLA-4 might be needed to regulate PDIA2-specific T cell clones that escaped thymic negative selection.
Experiments with OVA-reactive T cells and OVA-transgenic mice 41 have suggested the possibility of T reg cell-dependent and T reg cell-independent actions of CTLA-4. In contrast, our studies have examined the in vivo activity of self-reactive T cells that recognize an endogenous self antigen in the setting of CTLA-4 deficiency. By cloning endogenous PDIA2-specific TCRs from pancreas-infiltrating T cells in Ctla4 −/− mice, we found that CTLA-4 expression on PDIA2-specific T cells limited their in vivo pathogenicity by two mechanisms. In the absence of T reg cells, PDIA2-reactive T effector cells specifically accumulated in pancreatic lymph nodes regardless of CTLA-4 expression but infiltrated into the pancreas only in the absence of CTLA-4. This finding demonstrates a cell-autonomous action of CTLA-4, as CTLA-4 expression by the effector T cell was able to limit tissue injury in the absence of T reg cells. However, in the presence of T reg cells, Ctla4 −/− PDIA2-specific T cells were also prevented from infiltrating the pancreas. This result demonstrates cell-extrinsic regulation of Ctla4 −/− T cells by T reg cells, as suggested by published studies 12, 39 .
Although Ctla4 −/− mice have more Foxp3 + cells 31 , these T reg cells are reportedly nonfunctional in vivo 31 . Consistent with that finding, conditional deletion of CTLA-4 in T reg cells causes fatal systemic lymphproliferation 16 . However, those findings do not rule out the possibility of a cell-intrinsic action of CTLA-4 on effector cells. Indeed, CTLA-4 regulates effector T cell activation independently of T reg cells, as CTLA-4 expression in effector cells in mice with T reg cell-specific CTLA-4 deficiency can substantially delay the death of Ctla4 −/− mice 16 . A study of a tumor model has also demonstrated that CTLA-4 blockade not only on T reg cells but also effector T cells is required for maximum antitumor activity 42 . Our results add to that collection of findings, as CTLA-4 expression on PDIA2-specific T cells was sufficient to prevent tissue infiltration in the absence of T reg cells. In summary, we have shown that Ctla4 −/− T cells infiltrating peripheral nonlymphoid tissues are reactive to tissue-specific self antigens. By examining the activity of an authentic self-reactive T cell in the presence and absence of CTLA-4, and in the presence and absence of T reg cells, we found that CTLA-4 controls the pathogenicity of autoantigen-specific T cells by both cell-autonomous actions in effector T cells and non-cell-autonomous mechanisms in T reg cells.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
